- Joined
- Dec 3, 2017
- Messages
- 26,290
- Reaction score
- 16,771
- Gender
- Male
- Political Leaning
- Progressive
https://www.thedailybeast.com/anoth...panyand-they-teamed-up-on-its-behalf?ref=wrap
Rep. Chris Collins filed two bills that would have benefited Innate Immunotherapeutics—and his colleague Rep. Billy Long was only lawmaker to co-sponsor both.
As The Daily Beast reported last year, Collins authored four bills that would likely have benefited the company. Two of them, separate versions of the same bill introduced in the 114th and 115th Congresses, had just one co-sponsor: Rep. Billy Long (R-MO), a member of the House Energy and Commerce Subcommittee on Health, which has oversight over the Food and Drug Administration. While no one has accused him of any legal wrongdoing, Long also held stock in Innate. Long signed on to both pieces of legislation the day they were introduced. The first was filed in December 2016, and didn’t make it out of subcommittee before the session ended.
Then in January, Long bought between $15,000 and $50,000 in Innate stock, apparently as part of a Fidelity retirement account. In July, Collins once again introduced his bill, which would have expedited FDA approvals for treatments such as Innate’s, and Long was once again an immediate co-sponsor.
==================================================
D.C. under Trump is getting swampier & swampier.
Rep. Chris Collins filed two bills that would have benefited Innate Immunotherapeutics—and his colleague Rep. Billy Long was only lawmaker to co-sponsor both.
As The Daily Beast reported last year, Collins authored four bills that would likely have benefited the company. Two of them, separate versions of the same bill introduced in the 114th and 115th Congresses, had just one co-sponsor: Rep. Billy Long (R-MO), a member of the House Energy and Commerce Subcommittee on Health, which has oversight over the Food and Drug Administration. While no one has accused him of any legal wrongdoing, Long also held stock in Innate. Long signed on to both pieces of legislation the day they were introduced. The first was filed in December 2016, and didn’t make it out of subcommittee before the session ended.
Then in January, Long bought between $15,000 and $50,000 in Innate stock, apparently as part of a Fidelity retirement account. In July, Collins once again introduced his bill, which would have expedited FDA approvals for treatments such as Innate’s, and Long was once again an immediate co-sponsor.
==================================================
D.C. under Trump is getting swampier & swampier.